Andra AP-fonden’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,800
Closed -$552K 404
2024
Q3
$552K Sell
2,800
-8,100
-74% -$1.68M 0.01% 390
2024
Q2
$2.25M Sell
10,900
-300
-3% -$68K 0.04% 347
2024
Q1
$3.03M Buy
+11,200
New +$2.67M 0.05% 312
2023
Q3
Sell
-8,100
Closed -$1.7M 333
2023
Q2
$1.7M Buy
8,100
+5,800
+252% +$1.15M 0.04% 542
2023
Q1
$464K Buy
+2,300
New +$521K 0.01% 550
2022
Q3
Sell
-9,500
Closed -$2.03M 562
2022
Q2
$2.03M Buy
+9,500
New +$2.32M 0.06% 504
2021
Q4
$1.77M Sell
4,700
-2,300
-33% -$894K 0.04% 514
2021
Q3
$2.89M Buy
7,000
+1,400
+25% +$581K 0.06% 525
2021
Q2
$2.07M Buy
+5,600
New +$1.87M 0.04% 557

Other funds holding CRL